|Articles|December 30, 2022
Calyx Acquired by CapVest/GLO Healthcare
The financial transaction details pertaining to the eClinical technology provider's deal were not disclosed.
Advertisement
GLO Healthcare, a healthcare platform created by private equity investor CapVest Partners LLP, has completed the acquisition of Calyx, an software and services provider of medical imaging, IRT, CTMS, RIM and EDC for the clinical trials industry. The terms of the transaction are not being disclosed. Calyx will join GLO’s development and delivery of diagnostic testing for major cancers and other diseases.
Read more about
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
SCOPE X: The COPD Case Study That Shows What AI Can Do for Enrollment
3
SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years
4
A Shot in the Arm to Traditional Vaccine Trial Strategy
5